Teikoku USA
Manufacturing · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
1718 Ringwood Ave, San Jose, California,...Phone Number
(408) 501-1800Website
www.teikokuusa.comRevenue
$14.9 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
3
1
1
1
1
1
About Teikoku USA
Founded in 1997, Teikoku Pharma USA Inc., located in San Jose, California is a wholly-owned subsidiary of Teikoku Seiyaku Co., LTD. of Japan, is an international specialty pharmaceutical company that develops and manufactures pharmaceutical products based on its delivery platform technologies. Teikoku's main product is Lidoderm® (Lidocaine 5% Patch) for PHN, developed by Teikoku and distributed by Endo Pharmaceuticals in the U.S and Grunenthal GmbH in Europe and Latin America as Versatis®. Teikoku's internal therapeutic focus is in Pain Management, CNS and Oncology.Explore more
Teikoku USA Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Teikoku USA your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Teikoku USA is spiking on competitors!
Click to see if Teikoku USA had a recent Job posting/layoffs
Check if Teikoku USA has recently received funding, and reach out quickly before it becomes old news!
Teikoku USA, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Teikoku USA has new funding data
Earning: See what the market has to say on Teikoku USA recently announced quarterly report
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Teikoku USA
Product Launch: Get notified when Teikoku USA launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Teikoku USA
Compare insights from companies similar to Teikoku USA, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Teikoku USA is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Teikoku USA is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Teikoku USA.
Teikoku USA Tech Stack
A closer look at the technologies used by Teikoku USA
Teikoku USA News & Media
Teikoku Pharma USA announces positive topline results from Phase 2 clinical trial of TPU-006, non- opioid pain management patch in Abdominoplasty Surgery.
SAN JOSE, Sept. 6, 2023 /PRNewswire/ -- Teikoku Pharma USA, a global pharmaceutical company, today announced positive topline results from its Phase 2 proof of concept study of TPU-006, a 4-day dexmedetomidine transdermal patch for Post Surgical Pain. The double-blind, placebo-controlled,...Teikoku Pharma granted FDA Fast Track Designation for TPU-006, a Novel 4-day Dexmedetomidine Transdermal System for Post Operative Pain Management
SAN JOSE, June 21, 2023 /PRNewswire/ -- Teikoku Pharma USA, a global pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) granted Fast Track Designation for TPU-006 in managing postoperative pain. TPU-006 is an investigational 4-day dexmedetomidine...Teikoku Pharma granted FDA Fast Track Designation for TPU-006, a Novel 4-day Dexmedetomidine Transdermal System for Post Operative Pain Management
SAN JOSE, June 21, 2023 /PRNewswire/ -- Teikoku Pharma USA, a global pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) granted Fast Track Designation for TPU-006 in managing postoperative pain. TPU-006 is an investigational 4-day dexmedetomidine transdermal system, a novel drug delivery technology with a non-opioid active moiety for managing post-surgical pain. "We are excited by the FDA's decision to grant a Fast Track Designation for TPU-006 to address aLidocaine Patches Market is Projected to Showcase Booming Growth | Endo International, Viatris, Teikoku Pharma
BURLINGAME, CALIFORNIA, UNITED STATES, March 10, 2023 /EINPresswire.com/ -- Coherent Market Insights published a new research publication on Lidocaine Patches Market Insights, to 2030" with 150+pages and enriched with self-explained Tables and …
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Teikoku USA
Sign Up For FreeTo access detailed company insights
Founded in 1997, Teikoku Pharma USA Inc., located in San Jose, California is a wholly-owned subsidiary of Teikoku Seiyaku Co., LTD. of Japan, is an international specialty pharmaceutical company that develops and manufactures pharmaceutical products based on its delivery platform technologies. Teikoku's main product is Lidoderm® (Lidocaine 5% Patch... Read More
